Mirae Asset Global ETFs Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Mirae Asset Global ETFs Holdings's ABBV Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $5.6M and bringing the position to 224,280 shares worth $56.4M. The position accounts for 0.07% of the portfolio, ranked #257.
Mirae Asset Global ETFs Holdings first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $79.1M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 224,280 shares of AbbVie worth $56.4M as of Q2 2026.
- Mirae Asset Global ETFs Holdings bought 26,041 AbbVie shares in Q2 2026, an estimated $5.6M.
- AbbVie made up 0.07% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #257 holding.
- Mirae Asset Global ETFs Holdings first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's AbbVie position peaked at $79.1M in Q3 2025.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.